European Consortium Launches 10-year, $1.2B Diabetes Project

Jun 14, 2010

NEW YORK (GenomeWeb News) – The Innovative Medicines Initiative for Diabetes on Monday announced a €1 billion ($1.2 billion), 10-year project focusing on pancreatic islet cell function and survival.

The project will involve research into developing biomarkers and tools to better manage diabetes with the hope of curing the disease, which affects 285 million people worldwide, IMIDIA said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Concerns About Bias in Policies

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Reprogrammable DNA

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Lack of Diversity

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

This Week in Science

In Science this week: whole-genome sequencing of single sperm cells, and more.

Featured White Papers

Cardiovascular and Metabolic Disease

Apr

30

Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

Menu